HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yung Hyun Choi Selected Research

6,7-dihydroxyflavone

2/2015Apoptotic effects of 7,8-dihydroxyflavone in human oral squamous cancer cells through suppression of Sp1.
3/2013Apoptosis induction of human leukemia U937 cells by 7,8-dihydroxyflavone hydrate through modulation of the Bcl-2 family of proteins and the MAPKs signaling pathway.
7/20127,8-dihydroxyflavone induces G1 arrest of the cell cycle in U937 human monocytic leukemia cells via induction of the Cdk inhibitor p27 and downregulation of pRB phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yung Hyun Choi Research Topics

Disease

241Neoplasms (Cancer)
01/2024 - 12/2002
56Leukemia
01/2021 - 05/2005
55Carcinoma (Carcinomatosis)
07/2022 - 05/2002
47Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 05/2006
44Inflammation (Inflammations)
06/2024 - 01/2006
38Mitochondrial Diseases (Mitochondrial Disease)
05/2023 - 11/2007
32Hepatocellular Carcinoma (Hepatoma)
03/2023 - 01/2006
24Breast Neoplasms (Breast Cancer)
01/2021 - 02/2004
21Neoplasm Metastasis (Metastasis)
03/2020 - 09/2005
19Prostatic Neoplasms (Prostate Cancer)
06/2023 - 01/2003
18Lung Neoplasms (Lung Cancer)
07/2023 - 05/2002
16Melanoma (Melanoma, Malignant)
02/2024 - 12/2004
15Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 01/2002
14Colonic Neoplasms (Colon Cancer)
12/2019 - 11/2003
13Non-Muscle Invasive Bladder Neoplasms
01/2023 - 01/2010
9Infections
07/2022 - 11/2013
9Neurodegenerative Diseases (Neurodegenerative Disease)
11/2016 - 06/2007
8Hypoxia (Hypoxemia)
01/2024 - 11/2009
7Stomach Neoplasms (Stomach Cancer)
03/2021 - 02/2011
7Necrosis
01/2021 - 05/2006
7Renal Cell Carcinoma (Grawitz Tumor)
11/2018 - 06/2010
7Adenocarcinoma
03/2014 - 11/2007
6Squamous Cell Carcinoma of Head and Neck
01/2024 - 01/2015
6Fibrosis (Cirrhosis)
11/2023 - 01/2014
6Weight Loss (Weight Reduction)
12/2022 - 11/2019
6Bone Resorption
02/2022 - 12/2017
6Asthma (Bronchial Asthma)
12/2019 - 03/2008
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 08/2005
5Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2024 - 09/2011
5Carcinogenesis
12/2023 - 10/2016
5Chronic Disease (Chronic Diseases)
03/2023 - 06/2007
5Skin Diseases (Skin Disease)
09/2022 - 09/2013
5Rheumatoid Arthritis
05/2021 - 09/2007

Drug/Important Bio-Agent (IBA)

56Proteins (Proteins, Gene)FDA Link
02/2024 - 11/2007
44Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024 - 05/2002
38Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 12/2006
37CaspasesIBA
07/2023 - 12/2003
23Ethanol (Ethyl Alcohol)IBA
04/2024 - 05/2006
22NF-kappa B (NF-kB)IBA
06/2020 - 10/2003
21Caspase 3 (Caspase-3)IBA
01/2024 - 11/2003
21CytokinesIBA
05/2021 - 12/2006
21LigandsIBA
06/2019 - 05/2007
20Matrix Metalloproteinases (MMPs)IBA
06/2022 - 11/2008
18AntioxidantsIBA
07/2023 - 05/2006
17DNA (Deoxyribonucleic Acid)IBA
12/2022 - 10/2004
17Telomerase (Telomerase Reverse Transcriptase)IBA
03/2015 - 04/2005
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2019 - 04/2006
13LipopolysaccharidesIBA
05/2024 - 01/2008
13FlavonoidsIBA
01/2023 - 12/2008
13Cytochromes c (Cytochrome c)IBA
01/2023 - 02/2006
13Anthocyanins (Anthocyanin)IBA
03/2021 - 04/2009
12Messenger RNA (mRNA)IBA
07/2021 - 04/2006
11Biomarkers (Surrogate Marker)IBA
01/2024 - 07/2016
11Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2020 - 04/2004
11ResveratrolIBA
05/2019 - 01/2003
11beta-lapachoneIBA
02/2016 - 03/2003
10AlkaloidsIBA
01/2021 - 01/2008
9p38 Mitogen-Activated Protein KinasesIBA
06/2023 - 07/2009
9sulforaphaneIBA
09/2020 - 05/2007
9cordycepinIBA
01/2019 - 12/2010
8Transcription Factors (Transcription Factor)IBA
06/2023 - 11/2009
8MicroRNAs (MicroRNA)IBA
01/2023 - 10/2016
8PolyphenolsIBA
12/2022 - 05/2006
8Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 04/2012
8Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2018 - 10/2010
8sanguinarineIBA
01/2016 - 09/2007
7Melanins (Melanin)IBA
02/2024 - 10/2010
7Particulate MatterIBA
12/2022 - 07/2020
7Bile Acids and Salts (Bile Acids)IBA
06/2022 - 09/2003
7TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2021 - 02/2008
7esculetinIBA
05/2016 - 03/2008
6Phosphotransferases (Kinase)IBA
07/2023 - 12/2008
6Therapeutic UsesIBA
02/2023 - 04/2006
6Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2015
6Peptides (Polypeptides)IBA
11/2020 - 01/2008
6Caspase 9IBA
01/2020 - 03/2009
6Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2019 - 02/2009
6CurcuminIBA
05/2019 - 05/2006
6morinIBA
05/2019 - 10/2014
6baicaleinIBA
01/2019 - 01/2006
6Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019 - 01/2003
6quinone (benzoquinone)IBA
01/2015 - 11/2003
5SpermidineIBA
06/2023 - 03/2012
5Transcription Factor AP-1 (Transcription Factor AP 1)IBA
06/2023 - 05/2002
5fisetinIBA
05/2023 - 01/2020
5InterleukinsIBA
04/2023 - 10/2013
5bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
11/2021 - 02/2008
5Auranofin (Ridaura)FDA Link
05/2021 - 04/2017
5GenisteinIBA
08/2019 - 11/2007
5Bee Venoms (Bee Venom)IBA
01/2019 - 12/2006
5Dinoprostone (PGE2)FDA Link
10/2018 - 06/2007
5buteinIBA
02/2018 - 12/2009
5isothiocyanic acidIBA
01/2018 - 07/2007
5Histone Deacetylase InhibitorsIBA
01/2015 - 08/2005
5HS 1200IBA
10/2008 - 09/2003
5Chenodeoxycholic Acid (Chenix)FDA Link
10/2008 - 09/2003

Therapy/Procedure

22Therapeutics
02/2021 - 09/2003
14Traditional Medicine (Folk Remedies)
03/2020 - 06/2008
8Oral Administration
06/2024 - 04/2012
7Drug Therapy (Chemotherapy)
02/2023 - 04/2006